The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-butyl-4-methyl-4-phenyl-1H-imidazol-5(4H)-one ID: ALA4856425
PubChem CID: 164613537
Max Phase: Preclinical
Molecular Formula: C28H28N6O
Molecular Weight: 464.57
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCCC1=NC(C)(c2ccccc2)C(=O)N1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1
Standard InChI: InChI=1S/C28H28N6O/c1-3-4-14-25-29-28(2,22-10-6-5-7-11-22)27(35)34(25)19-20-15-17-21(18-16-20)23-12-8-9-13-24(23)26-30-32-33-31-26/h5-13,15-18H,3-4,14,19H2,1-2H3,(H,30,31,32,33)
Standard InChI Key: RRFIJSWWTWPMAC-UHFFFAOYSA-N
Molfile:
RDKit 2D
35 39 0 0 0 0 0 0 0 0999 V2000
3.0413 -12.4040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2163 -12.3998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2921 -13.1899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3652 -11.4165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3640 -12.2439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0789 -12.6568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7953 -12.2434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7924 -11.4129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0771 -11.0037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5069 -12.6541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5068 -13.4802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2210 -13.8915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9359 -13.4777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9319 -12.6485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2171 -12.2409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2130 -11.4173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8782 -10.9294 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.6199 -10.1459 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.7949 -10.1495 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.5434 -10.9352 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.6506 -11.0042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9362 -11.4169 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.1831 -11.0770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6312 -11.6903 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8507 -12.2329 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4640 -12.7847 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.0134 -10.2697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2294 -10.0130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0598 -9.2055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2758 -8.9488 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7356 -13.7969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9858 -14.5822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7927 -14.7584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3487 -14.1432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0955 -13.3603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
3 1 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
7 10 1 0
16 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 16 2 0
15 16 1 0
4 21 1 0
21 22 1 0
22 23 1 0
23 24 2 0
24 1 1 0
1 25 1 0
25 22 1 0
25 26 2 0
23 27 1 0
27 28 1 0
28 29 1 0
29 30 1 0
3 31 2 0
31 32 1 0
32 33 2 0
33 34 1 0
34 35 2 0
35 3 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 464.57Molecular Weight (Monoisotopic): 464.2325AlogP: 5.38#Rotatable Bonds: 8Polar Surface Area: 87.13Molecular Species: ACIDHBA: 5HBD: 1#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 4.24CX Basic pKa: 3.23CX LogP: 5.49CX LogD: 4.13Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.38Np Likeness Score: -0.71
References 1. Hernandez-Olmos V, Heering J, Bischoff-Kont I, Kaps A, Rajkumar R, Liu T, Fürst R, Steinhilber D, Proschak E.. (2021) Discovery of Irbesartan Derivatives as BLT2 Agonists by Virtual Screening., 12 (8.0): [PMID:34413955 ] [10.1021/acsmedchemlett.1c00240 ] 2. Yokomizo, T T, Kato, K K, Terawaki, K K, Izumi, T T and Shimizu, T T. 2000-08-07 A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders. [PMID:10934230 ] 3. Iizuka, Yoshiko Y and 5 more authors. 2005-07-01 Characterization of a mouse second leukotriene B4 receptor, mBLT2: BLT2-dependent ERK activation and cell migration of primary mouse keratinocytes. [PMID:15866883 ] 4. Okuno, Toshiaki and 5 more authors. 2008-04-14 12(S)-Hydroxyheptadeca-5Z, 8E, 10E-trienoic acid is a natural ligand for leukotriene B4 receptor 2. [PMID:18378794 ]